RBP-6000 is an extended-release formulation of buprenorphine given as monthly subcutaneous injections, with doses adjusted between 100 mg and 300 mg. It is studied in patients with opioid use disorder and opioid-related disorders.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.